DAVID S. SNYDER
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
MICHAEL FALK, MICHAEL E. FALK, KENNETH C. HUNT, CRAIG JANUARY, CRAIG T. JANUARY, CHRISTOPHER KENDRICK-PARKER, LEONARD T. LOVENTHAL, GREGORY LYNCH, GREGORY J. LYNCH, EMILE NUWAYSIR, EMILE F. NUWAYSIR, ROBERT J. PALAY, THOMAS M. PALAY, CHRISTOPHER PARKER, CHRISTOPHER J. PARKER, STANLEY ROSE, STANLEY D. ROSE, SHELI Z. ROSENBERG, NICHOLAS SEAY, NICHOLAS J. SEAY, DAVID SNYDER, JAMES A. THOMSON, MICHAEL J. VAN HANDEL
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-08-22
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-09-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-09-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-10-13
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Debt
2013-06-28

